Cutler Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1K Hold
40
﹤0.01% 1952
2023
Q4
$1K Buy
+40
New +$2.44K ﹤0.01% 3274
2023
Q1
Sell
-383
Closed -$52K 3824
2022
Q4
$52K Sell
383
-50
-12% -$7.04K ﹤0.01% 1543
2022
Q3
$54K Sell
433
-301
-41% -$34.1K ﹤0.01% 1832
2022
Q2
$60K Buy
+734
New +$56.9K ﹤0.01% 1808
2021
Q4
Sell
-279
Closed -$65.8K 5389
2021
Q3
$69K Buy
+279
New +$79.8K ﹤0.01% 2224
2020
Q3
Sell
-18
Closed -$14K 4678
2020
Q2
$14K Sell
18
-75
-81% -$56.6K ﹤0.01% 2617
2020
Q1
$55K Buy
+93
New +$90.6K ﹤0.01% 1664
2019
Q3
Sell
-571
Closed -$872K 4083
2019
Q2
$941K Buy
571
+301
+111% +$521K 0.09% 202
2019
Q1
$550K Buy
+270
New +$475K 0.06% 292
2018
Q4
Sell
-355
Closed -$545K 3944
2018
Q3
$671K Sell
355
-344
-49% -$711K 0.05% 381
2018
Q2
$1.42M Buy
699
+178
+34% +$406K 0.11% 184
2018
Q1
$1.15M Sell
521
-444
-46% -$1.13M 0.1% 201
2017
Q4
$2.23M Buy
965
+727
+305% +$1.48M 0.09% 152
2017
Q3
$423K Sell
238
-372
-61% -$520K 0.02% 738
2017
Q2
$830K Buy
610
+425
+230% +$513K 0.03% 469
2017
Q1
$217K Sell
185
-1,216
-87% -$1.24M 0.01% 1121
2016
Q4
$1.12M Buy
1,401
+129
+10% +$102K 0.04% 376
2016
Q3
$1.12M Sell
1,272
-57
-4% -$41.3K 0.05% 290
2016
Q2
$745K Sell
1,329
-1,477
-53% -$837K 0.04% 401
2016
Q1
$1.54M Sell
2,806
-1,428
-34% -$877K 0.1% 167
2015
Q4
$3.52M Buy
+4,234
New +$4.23M 0.2% 79

Other funds holding BLUE

Cutler Group's BLUE Position: Q1 2024 in Review

Cutler Group held its bluebird bio (BLUE) position steady in Q1 2024 at 40 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Cutler Group first reported a position in BLUE in Q4 2015 and has held it in 22 quarters since. The position peaked at $3.52M in Q4 2015. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Cutler Group held 40 shares of bluebird bio worth $1K as of Q1 2024.
  • Cutler Group left its bluebird bio share count unchanged in Q1 2024.
  • bluebird bio made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1952 holding.
  • Cutler Group first reported a position in bluebird bio in Q4 2015 and has held it in 22 quarters since.
  • Cutler Group's bluebird bio position peaked at $3.52M in Q4 2015.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.